Emerald Mutual Fund Advisers Trust Purchases New Shares in Plexus Corp. $PLXS

Emerald Mutual Fund Advisers Trust purchased a new position in Plexus Corp. (NASDAQ:PLXS) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 102,278 shares of the technology company’s stock, valued at approximately $20,715,000. Plexus comprises approximately 1.0% of Emerald Mutual Fund Advisers Trust’s holdings, making the stock its 29th biggest position.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Covestor Ltd increased its position in Plexus by 207.7% during the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock valued at $35,000 after acquiring an additional 162 shares during the last quarter. Allworth Financial LP lifted its holdings in shares of Plexus by 70.1% in the 3rd quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock worth $36,000 after acquiring an additional 103 shares during the last quarter. Johnson Financial Group Inc. bought a new stake in shares of Plexus in the 3rd quarter worth about $72,000. Farther Finance Advisors LLC boosted its stake in shares of Plexus by 114.7% during the 4th quarter. Farther Finance Advisors LLC now owns 511 shares of the technology company’s stock worth $75,000 after purchasing an additional 273 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Plexus by 583.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock worth $78,000 after purchasing an additional 490 shares during the period. 94.45% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

PLXS has been the topic of several analyst reports. Benchmark reiterated a “buy” rating and set a $220.00 price target on shares of Plexus in a report on Monday, March 16th. Weiss Ratings raised shares of Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, July 6th. Wall Street Zen upgraded Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Raymond James Financial reaffirmed an “outperform” rating and set a $275.00 target price on shares of Plexus in a research note on Thursday, April 30th. Finally, Needham & Company LLC increased their price target on Plexus from $285.00 to $310.00 and gave the stock a “buy” rating in a report on Monday, June 1st. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $246.67.

Insider Activity at Plexus

In other news, insider Michael J. Running sold 510 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $272.17, for a total transaction of $138,806.70. Following the transaction, the insider directly owned 665 shares of the company’s stock, valued at approximately $180,993.05. This trade represents a 43.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Angelo Michael Ninivaggi, Jr. sold 3,270 shares of Plexus stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $264.75, for a total transaction of $865,732.50. Following the sale, the executive vice president directly owned 16,266 shares of the company’s stock, valued at $4,306,423.50. This represents a 16.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 21,981 shares of company stock valued at $5,855,318 in the last quarter. Corporate insiders own 1.78% of the company’s stock.

Plexus Stock Down 3.1%

Shares of PLXS opened at $259.03 on Tuesday. The firm has a market capitalization of $6.93 billion, a P/E ratio of 37.87 and a beta of 0.88. Plexus Corp. has a 12-month low of $115.35 and a 12-month high of $307.06. The company has a current ratio of 1.54, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The firm has a fifty day moving average price of $275.87 and a 200-day moving average price of $224.53.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings results on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.18. The firm had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.13 billion. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The business’s revenue for the quarter was up 18.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.66 earnings per share. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Equities research analysts expect that Plexus Corp. will post 5.98 earnings per share for the current year.

Plexus Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.